JENNIFER DARKOWSKI: Open Payments
NPI 1285656710 · BETHEL PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,947 in 44 payments from 17 companies in 2025. Trend: 2023 $1,632 · 2024 $3,623 · 2025 $1,947
Food & beverage: $1,947
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $419 |
| ABBVIE INC. | 9 | $404 |
| Novo Nordisk Inc | 8 | $301 |
| AstraZeneca Pharmaceuticals LP | 3 | $157 |
| Otsuka America Pharmaceutical, Inc. | 3 | $153 |
| Phathom Pharmaceuticals, Inc. | 2 | $144 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| Lilly USA, LLC | 3 | $52 |
| Agios Pharmaceuticals, Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: QULIPTA, OTEZLA, Ozempic, REXULTI, AIRSUPRA, VOQUEZNA, REPATHA, SPRAVATO.
Industry payments across PA — which companies pay providers there.
